SELECT ISSUE


MÆDICA - a Journal of Clinical Medicine | Vol. 14, No. 2, 2019
ISSN 1841-9038  |  e-ISSN 2069-6116
ISSN-L 1841-9038
CNCSIS - CMR - B+

HIGHLIGHTS

Plagiatul – in actualitate

Tema plagiatului este tot mai mult discutata in ultima vreme. Aparitia unor programe performante de cautare si identificare a similitudinilor intre texte [...]

Committe on Publication Ethics

A forum for responsible and ethical research publishing – Code of Conduct and Best Practice Guidelines for Journal Editors.

Members Area


Present and Future in Treatment of Hodgkin Lymphoma

, , , , , , , , and

ABSTRACT

Hodgkin lymphoma is a highly curable malignant hemopathy, using chemotherapy, radiotherapy, target therapies and hematopoietic stem cell transplantation. Current research in this field focuses on identifying prognostic factors associated with the pathogenic characteristics of the tumoral process, enabling the therapy to be adjusted to each patient’s degree of risk.
The identification of biomarkers associated with the tumoral process is extremely important because these molecules can be targets for new biological therapies.
Keywords: Hodgkin lymphoma, tumoral microenvironment, treatment, innovative therapy

Full text | PDF